SRC and esophageal squamous cell carcinoma: Several studies have shown that aberrant activation of SRC or other SFK members promotes tumorigenesis in esophageal (ESCC), head and neck (HNSCC) and lung squamous cell carcinomas (LSCC) (5, 12, 13).